Výsledky vyhledávání - "Marc Maslanka"

Safety of desirudin in thrombosis prevention after total knee arthroplasty: the DESIR-ABLE study

Autor: Amir K. Jaffer, Maurice Jove, Marc Maslanka, Harold S. Minkowitz

Publikováno v: American journal of therapeutics. 21(6)

Desirudin, administered 30 minutes before total hip arthroplasty is superior to enoxaparin in preventing proximal deep vein thrombosis (DVT) and pulmonary embolism (PE) with similar bleeding. The purpose of this study was to determine the safety of d

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::2328d90f4da29d0a45a48f8c9b229b24
https://pubmed.ncbi.nlm.nih.gov/23344102

Zobrazit plný text záznamu

Safety of Desirudin Administered in the Immediate Postoperative Period Following Joint Replacement Surgery: An Observational Study

Autor: Maurice Jove, Marc Maslanka, James Meyer

Publikováno v: Blood. 124:5085-5085

INTRODUCTION. Desirudin is a recombinant direct thrombin inhibitor (DTI) approved in the US for the prophylaxis of deep vein thrombosis (DVT), which may lead to pulmonary embolism (PE), in patients undergoing elective hip replacement surgery, and app

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_________::51889b3ad20aa4ebadb75c2c71352a4b
https://doi.org/10.1182/blood.v124.21.5085.5085

Zobrazit plný text záznamu

Vyhledávací nástroje:

Upřesnit hledání